Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ABBOTT LABORATORIES | CHAIRMAN AND CEO, Director | Common shares without par value | 220K | $26.4M | $120.05 | Feb 29, 2024 | Direct |
ABBOTT LABORATORIES | CHAIRMAN AND CEO, Director | Common shares without par value | 220K | $25.7M | $116.90 | Sep 12, 2024 | Direct |
ABBOTT LABORATORIES | CHAIRMAN AND CEO, Director | Common shares without par value | 197K | $23.4M | $118.50 | Feb 29, 2024 | Ford Family Trust |
ABBOTT LABORATORIES | CHAIRMAN AND CEO, Director | Common shares without par value | 197K | $23.1M | $116.90 | Sep 12, 2024 | Ford Family Trust |
ABBOTT LABORATORIES | CHAIRMAN AND CEO, Director | Option (right to buy) | 264K | Feb 21, 2024 | Direct | ||
ABBOTT LABORATORIES | CHAIRMAN AND CEO, Director | Option (right to buy) | 0 | Sep 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | Sep 12, 2024 | 6 | -$9.81M | 4 | Sep 13, 2024 | CHAIRMAN AND CEO, Director |
ABT | ABBOTT LABORATORIES | Feb 29, 2024 | 1 | -$3.79M | 4 | Mar 4, 2024 | CHAIRMAN AND CEO, Director |
ABT | ABBOTT LABORATORIES | Feb 21, 2024 | 2 | $0 | 4 | Feb 23, 2024 | CHAIRMAN AND CEO, Director |
ABT | ABBOTT LABORATORIES | Feb 28, 2023 | 1 | -$3.07M | 4 | Mar 2, 2023 | CHAIRMAN AND CEO, Director |
ABT | ABBOTT LABORATORIES | Feb 17, 2023 | 2 | $0 | 4 | Feb 22, 2023 | CHAIRMAN AND CEO, Director |
ABT | ABBOTT LABORATORIES | Aug 25, 2022 | 5 | -$6.64M | 4 | Aug 26, 2022 | CHAIRMAN AND CEO, Director |
ABT | ABBOTT LABORATORIES | Mar 25, 2022 | 2 | $0 | 4 | Apr 1, 2022 | CHAIRMAN AND CEO, Director |
ABT | ABBOTT LABORATORIES | Feb 28, 2022 | 1 | -$3.25M | 4 | Mar 2, 2022 | CHAIRMAN AND CEO, Director |
ABT | ABBOTT LABORATORIES | Feb 18, 2022 | 2 | $0 | 4 | Feb 23, 2022 | CHAIRMAN AND CEO, Director |
ABT | ABBOTT LABORATORIES | Jun 25, 2021 | 2 | $0 | 4 | Jul 2, 2021 | PRESIDENT AND CEO, Director |